Wesley J. Talcott, MD, MBA

Articles by Wesley J. Talcott, MD, MBA

Dr Talcott on Treatment De-Escalation in Elderly Patients With Breast Cancer

September 27th 2023

Wesley J. Talcott, MD, MBA, discusses the importance of de-escalating therapy in patients with breast cancer, highlighting use of personalized treatment approaches.

Creating the In-Person Experience on a Virtual Platform

ByMeriem Mokhtech, MD,Wesley J. Talcott, MD, MBA,Henry S. Park, MD, MPH

December 25th 2020

The coronavirus disease 2019 crisis has changed all aspects of medical education but perhaps altered clinical education most dramatically.

Wesley J. Talcott, MD, MBA

Articles by Wesley J. Talcott, MD, MBA

Dr Talcott on Treatment De-Escalation in Elderly Patients With Breast Cancer

Creating the In-Person Experience on a Virtual Platform

Latest Updated Articles

Trending on OncLive

FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma

Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma